Genius Sports Limited (NYSE: GENI) stock jumped 4.31% on Monday to $5.33 against a previous-day closing price of $5.11. With 1.47 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.79 million shares. During the session, the Internet Content & Information company that operates in wider Communication Services sector, reached to the highest price of $5.45 whereas the lowest price it dropped to was $5.13. The 52-week range on GENI shows that it touched its highest point at $8.45 and its lowest point at $3.12 during that stretch. It currently has a 1-year price target of $8.95. Beta for the stock currently stands at 1.98.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of GENI was up-trending over the past week, with a rise of 3.70%, but this was up by 6.60% over a month. The stock gained 18.71% in the past year, while it has gained 49.30% so far this year. A look at the trailing 12-month EPS for GENI yields -0.86 with Next year EPS estimates of -0.12. For the next quarter, that number is -0.07. This implies an EPS growth rate of 67.89% for this year and 58.06% for next year.
Float and Shares Shorts:
At present, 201.85 million GENI shares are outstanding with a float of 126.16 million shares on hand for trading. On Oct 30, 2023, short shares totaled 7.17 million, which was 3.05% higher than short shares on Sep 28, 2023. In addition to Mr. Mark Locke as the firm’s Co-Founder, CEO & Director, Mr. Nicholas Taylor serves as its Chief Financial Officer.
Other institutions hold 39.69% of GENI, in contrast to 13.46% held by mutual funds. As the largest shareholder in GENI with 9.48% of the stake, Caledonia holds 20,526,210 shares worth 20,526,210. A second-largest stockholder of GENI, Granahan Investment Management, L, holds 14,404,297 shares, controlling over 6.65% of the firm’s shares. Nikko Asset Management Americas, is the third largest shareholder in GENI, holding 7,047,580 shares or 3.25% stake. With a 2.80% stake in GENI, the ARK Next Generation Internet ETF is the largest stakeholder. A total of 6,072,243 shares are owned by the mutual fund manager. The MFS New Discovery Fund, which owns about 1.35% of GENI stock, is the second-largest Mutual Fund holder. It holds 2,915,388 shares valued at 14.23 million. Granahan Funds Plc – US Focused G holds 0.93% of the stake in GENI, owning 2,003,731 shares worth 9.78 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for GENI since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With GENI analysts setting a high price target of $12.00 and a low target of $7.00, the average target price over the next 12 months is $8.95. Based on these targets, GENI could surge 125.14% to reach the target high and rise by 31.33% to reach the target low. Reaching the average price target will result in a growth of 67.92% from current levels.
Summary of Insider Activity:
Insiders traded GENI stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.